F293-0988 Screening compound: 5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

F293-0988 Screening compound: 5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid
F293-0988 Screening compound: 5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F293-0988
5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F293-0988

Molecular Formula

C24H32N4O5S (C24 H32 N4 O5 S)

Compound Name

5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

IUPAC name

5-(4-ethoxybenzenesulfonamido)-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

SMILES

CCOc(cc1)ccc1S(Nc(cc1C(O)=O)cnc1N1CC(CN2CCCC2)CCC1)(=O)=O

InChI

InChI=1S/C24H32N4O5S/c1-2-33-20-7-9-21(10-8-20)34(31,32)26-19-14-22(24(29)30)23(25-15-19)28-13-5-6-18(17-28)16-27-11-3-4-12-27/h7-10,14-15,18,26H,2-6,11-13,16-17H2,1H3,(H,29,30)/t18-/m1/s1

InChI Key

WNADAVBOKAAUCK-GOSISDBHSA-N

MDL Number (MFCD)

MFCD27113027

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

488.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.691

Distribution Coefficient, logD

3.691

Water Solubility, LogSw

-3.72

Polar Surface Area

92.975

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

9.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

F293-0988 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Eccentric PPI Library (11937 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F293-0988 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F293-0988?
Check Price and Availability of F293-0988, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F293-0988 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F293-0988
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F293-0988
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F293-0988 available by request